Bristol Megace
Executive Summary
Circuit appeals court hearing on Bristol's Megace patent infringement case against Par Pharmaceutical scheduled for July 12. The New York Southern District Court dismissed Bristol's argument regarding oral megestrol Dec. 14 (1"The Pink Sheet" Jan. 1, In Brief)